Steenbeek MP

ORCID: 0000-0001-6097-1579 · 4 papers in corpus · active 2018-2025
2025
Pathogenesis of peritoneal high-grade serous carcinoma after risk-reducing surgery: a systematic review.
The journal of pathology. Clinical research ·doi:10.1002/2056-4538.70037

Germline BRCA1/2 pathogenic variant carriers have an increased risk for high-grade serous carcinoma (HGSC) and are therefore advised to have risk-reducing salpingo-oophorectomy around the age of 40. However, a risk of 0.9% to develop perito…

2025
Salpingectomy With Delayed Oophorectomy Versus Salpingo-Oophorectomy in BRCA1/2 Carriers: Three-Year Outcomes of a Prospective Preference Trial.
BJOG : an international journal of obstetrics and gynaecology ·doi:10.1111/1471-0528.18075

ObjectiveTo compare menopause-related quality of life (QoL) after risk-reducing salpingectomy (RRS) versus risk-reducing salpingo-oophorectomy (RRSO) until 3 years of post-surgery.DesignA prospective study (TUBA study) with treatment alloca…

2021
Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.
JAMA oncology ·doi:10.1001/jamaoncol.2021.1590

ImportanceMost women with a BRCA1/2 pathogenic variant undergo premature menopause with potential short- and long-term morbidity due to the current method of ovarian carcinoma prevention: risk-reducing salpingo-oophorectomy (RRSO). Because …

2018
Noninvasive diagnostic tools for pelvic congestion syndrome: a systematic review.
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.13311

IntroductionIn the work-up of patients with suspected pelvic congestion syndrome, venography is currently the gold standard. Yet if non-invasive diagnostic tools are found to be accurate, invasive venography might no longer be indicated as …